Varian Medical Systems, Inc. (NYSE:VAR) registered a -12.52% decrease, still its new closing price is 6.15% up from the company’s 1 year high of 106.70.It posted -13.69% losses in previous 5 sessions and is now the subject of 6 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 1 buy or better ratings. The 8 stock analysts following this company have an average price target at $91.38, with individual PT in the $81.50-$102.00 range. The shares moved at $77.68, implying that brokerage firms see shares gaining about 0.71% in twelve months time.
Varian Medical Systems, Inc. (VAR) SEC Form 4 News
The stock is getting much attention these days as insiders are offloading shares while they posted a -13.48% fall year to date. A President and CEO at Varian Medical Systems, Inc. (VAR) offloaded shares in a transaction closed on Thursday January 05, 2017. WILSON DOW R sold 13,334 shares in the company at $88.74 each and collected $1,183,000 in proceeds. WILSON DOW R now owns 64,291 shares in the company after this transaction. A SVP, Gen Counsel and Secretary in the company, KUO JOHN W, disclosed a transaction on Thursday December 08, 2016 that ended up generating $114,000 from the sale of 1,267 shares at $90.33 per share.
Varian Medical Systems, Inc. (NYSE:VAR) Upcoming Results on Tap
Varian Medical Systems, Inc. will next provide financial results for the December 2017 quarter. Stock analysts expect it to report per-share earnings of $1.21 in that period. Sales during the quarter are predicted to arrive at $811.27 million.
Earnings surprise history: Last quarter, the company posted approximately $763.3 million in revenue and EPS of $0.75. The mean forecast was for $766.39 million and $1.05 a share, respectively. One quarter earlier, revenue for the stock was at $912.5 million, with earnings at $1.38/share.
Varian Medical Systems, Inc. (VAR) Brokerage Update
Varian Medical Systems, Inc. (VAR) is in Robert W. Baird’s research list so their analyst rating change is noteworthy. These shares were downgraded to Neutral from Outperform by Robert W. Baird, according to news reported on Tuesday October 20, 2015.Another important research note was issued by Goldman on Monday September 28, 2015.The firm downgraded VAR to Sell from Neutral. Over the last six months and over the last three months, the shares of Varian Medical Systems, Inc. (VAR), have changed -18.01% and -13.64%, respectively.